CompletedPhase 4

Dosage of Epidural Morphine in Elderly Patients

Egypt96 participantsStarted 2020-03-20

Plain-language summary

This a clinical trial that evaluates the efficacy and safety of three different doses of morphine, namely 1.5 mg, 3 mg and 4.5 mg, via the epidural route regarding reducing pain in elderly patients after a cancer surgery in the lower abdomen

Who can participate

Age range60 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patient refusal.
✕. Patients who are morbidly obese (body mass index ≥ 40 kg/m2).
✕. Those with contraindications to neuraxial analgesia. 4- psychiatric illness that would interfere with the perception and the assessment of pain.

What they're measuring

Total Patient-controlled Analgesia (PCA) Morphine Sulphate (MS) Consumption.

Timeframe: 72 hours

Trial details

NCT IDNCT04316871

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

Results submitted2024-07-13

View on ClinicalTrials.gov More Age Problem trials